These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34953597)

  • 1. Sequential Liver, Kidney, and Autologous Stem Cell Transplant for AL Amyloidosis: A Case Report.
    Sevmis M; Aktas S; Alkara U; Kilercik H; Göksoy HS; Uyar M; Sevmis S
    Transplant Proc; 2022; 54(1):197-201. PubMed ID: 34953597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous stem cell transplantation following simultaneous liver and kidney transplantation in severe amyloid light chain amyloidosis associated with multiple myeloma: a case report.
    Al-Zoairy R; Viveiros A; Zoller H; Schneeberger S; Oberhuber G; Gunsilius E; Tilg H; Wolf D; Rudzki JD
    J Med Case Rep; 2020 Oct; 14(1):201. PubMed ID: 33099313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement.
    Leung N; Griffin MD; Dispenzieri A; Haugen EN; Gloor JM; Schwab TR; Textor SC; Lacy MQ; Litzow MR; Cosio FG; Larson TS; Gertz MA; Stegall MD
    Am J Transplant; 2005 Jul; 5(7):1660-70. PubMed ID: 15943624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved.
    Al Saleh AS; Sidiqi MH; Muchtar E; Dispenzieri A; Buadi FK; Dingli D; Lacy MQ; Warsame RM; Gonsalves WI; Kourelis TV; Hogan WJ; Hayman SR; Kapoor P; Kumar SK; Gertz MA
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1520-1525. PubMed ID: 31054986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis.
    Sidiqi MH; Buadi FK; Dispenzieri A; Warsame R; Lacy MQ; Dingli D; Leung N; Gonsalves WI; Kapoor P; Kourelis TV; Hogan WJ; Kumar SK; Gertz MA
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):e108-e111. PubMed ID: 30529461
    [TBL] [Abstract][Full Text] [Related]  

  • 6.  Liver transplantation followed by autologous stem cell transplantation for acute liver failure caused by AL amyloidosis. Case report and review of the literature.
    Elnegouly M; Specht K; Zoller H; Matevossian E; Bassermann F; Umgelter A
    Ann Hepatol; 2016; 15(4):592-7. PubMed ID: 27236160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.
    Worel N; Schulenburg A; Mitterbauer M; Keil F; Rabitsch W; Kalhs P; Gisslinger H; Raderer M; Geissler K; Höcker P; Zielinski CC; Oberbauer R; Greinix HT
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous rupture of the liver in a patient with systemic AL amyloidosis undergoing treatment with high-dose melphalan and autologous stem cell transplantation: a case report with literature review.
    Tam M; Seldin DC; Forbes BM; Connors LH; Skinner M; Oran B; Quillen K; Sanchorawala V
    Amyloid; 2009; 16(2):103-7. PubMed ID: 20536404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and prognosis of a Chinese cohort with systemic light chain amyloidosis: a single-center study.
    Xie W; Wang Q; Zhou F; Wang S; Sun Y; Cen X; Ren H; Qiu Z; Dong Y
    Int J Hematol; 2023 Aug; 118(2):231-241. PubMed ID: 37247070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of autologous stem cell transplant for cardiac AL-amyloidosis and cardiac light chain deposition disease.
    Abdallah AA; Alapat D; Kaur V; Atrash S
    J Oncol Pharm Pract; 2020 Jul; 26(5):1128-1133. PubMed ID: 31795821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review.
    Gertz MA; Dispenzieri A
    JAMA; 2020 Jul; 324(1):79-89. PubMed ID: 32633805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Autologous Stem Cell Transplantation in Amyloidosis.
    Vaxman I; Dispenzieri A
    Oncology (Williston Park); 2021 Aug; 35(8):471-478. PubMed ID: 34398591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late onset renal failure and nephrotic syndrome after autologous stem cell transplant for Al amyloidosis.
    Rifkin SI; Weinstein SS
    Ren Fail; 2012; 34(5):664-6. PubMed ID: 22452410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daratumumab, pomalidomide, and dexamethasone as a bridging therapy to autologous stem cell transplantation in a case of systemic light-chain amyloidosis with advanced cardiac involvement.
    Arnall JR; Usmani SZ; Adamu H; Mishkin J; Bhutani M
    J Oncol Pharm Pract; 2019 Jun; 25(4):1021-1025. PubMed ID: 30477388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heart transplantation and follow-up treatment with AL-amyloidosis in 5 patients].
    Adam Z; Ozábalová E; Němec P; Bedáňová H; Kuman M; Krejčí J; Špinarová L; Žampachová V; Čermáková Z; Pour L; Krejčí M; Sanecká V; Štork M; Pika T; Straub J; Adamová D; Stavařová Y; Král Z; Mayer J
    Vnitr Lek; 2018; 64(4):441-449. PubMed ID: 29791180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deferred autologous stem cell transplantation in systemic AL amyloidosis.
    Manwani R; Hegenbart U; Mahmood S; Sachchithanantham S; Kyriakou C; Yong K; Popat R; Rabin N; Whelan C; Dittrich T; Kimmich C; Hawkins P; Schönland S; Wechalekar A
    Blood Cancer J; 2018 Nov; 8(11):101. PubMed ID: 30397193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
    Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV
    Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 24-year experience of autologous stem cell transplantation for light chain amyloidosis patients in the United Kingdom.
    Sharpley FA; Petrie A; Mahmood S; Sachchithanantham S; Lachmann HJ; Gillmore JD; Whelan CJ; Fontana M; Martinez-Naharro A; Quarta C; Hawkins PN; Wechalekar AD
    Br J Haematol; 2019 Dec; 187(5):642-652. PubMed ID: 31410841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heart transplantation in AL amyloidosis].
    Dahlberg P; Bartfay SE; Karason K; Mellqvist UH; Bollano E
    Lakartidningen; 2018 Mar; 115():. PubMed ID: 29583159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease.
    Batalini F; Econimo L; Quillen K; Sloan JM; Sarosiek S; Brauneis D; Havasi A; Stern L; Dember LM; Sanchorawala V
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):127-132. PubMed ID: 28865972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.